Novartis Vaccines PIPs?

Anonymous

Guest
Is it true that more than 80% of the vaccine sales force is on a PIP? My manager and I were talking about different opportunities within the company and he just threw that comment out there as if everyone already knows about this. Is it true?
 


















Really? Is this a traditional PIP? As I understand a PIP they give you a bunch of goofy sh!t to do and if you don't perfectly comply they can you whenever they want, at any time. How can 90% of a sales force be on a PIP if the PIP has any true meaning?

It would be comical if 80-90% of Field was on a PIP since PIPs are meant to provide Mgmt and Mkting scapegoats for product failures. Really, the whole field sucks?

Based on your own description of a PIP what meaning did you give it?
 






It would be comical if 80-90% of Field was on a PIP since PIPs are meant to provide Mgmt and Mkting scapegoats for product failures. Really, the whole field sucks?

Based on your own description of a PIP what meaning did you give it?

I always assumed that a PIP was the paper trail a manager needed to get rid of a rep who was either truly not doing his or her job or, more often than not, a rep who isn't liked by his manager. It is a plan of difficult/impossible goals for the rep which is normally designed so the rep does not succeed and can be gotten rid of without the threat of an expensive lawsuit.
This idea of 80-90% of the sales force being on a PIP means that:
1) The product sucks
2) Management of the company sucks
3) That management had a 80-90% failure rate in picking the right reps.
 






I always assumed that a PIP was the paper trail a manager needed to get rid of a rep who was either truly not doing his or her job or, more often than not, a rep who isn't liked by his manager. It is a plan of difficult/impossible goals for the rep which is normally designed so the rep does not succeed and can be gotten rid of without the threat of an expensive lawsuit.
This idea of 80-90% of the sales force being on a PIP means that:
1) The product sucks
2) Management of the company sucks
3) That management had a 80-90% failure rate in picking the right reps.

The only question I have is it only one of those factors, two, or all three?
 






The guy that said 90% is yanking your chain. I am an upper management elite & I'll have you know management only does things 110% or doesn't do them at all.

Therefore not only will all of you get pipped out but we'll draw an additional 10%
of reps from any salesforce, out of the hat our multi million $ paid consultants provide us with & whack them too !
 






The guy that said 90% is yanking your chain. I am an upper management elite & I'll have you know management only does things 110% or doesn't do them at all.

Therefore not only will all of you get pipped out but we'll draw an additional 10%
of reps from any salesforce, out of the hat our multi million $ paid consultants provide us with & whack them too !

That'll learn 'em!
 


















Is it true that more than 80% of the vaccine sales force is on a PIP? My manager and I were talking about different opportunities within the company and he just threw that comment out there as if everyone already knows about this. Is it true?

This is true. Menveo is a dog with a finite limit as to how much it can grow due to the fact that it needs to be reconstituted. Unlike vaccines like pentacel, that reconstitution can't be justified with shot savings or schedule convenience. Also, we're running up against the sanofi contracts and those are pretty entrenched. We were able to draw out some of that business for awhile but sanofi is getting more aggressive about contract compliance and it's getting harder to convince docs they can buy some Menveo while on their sanofi agreement. And, don't even get me started on Menactra's 9 month indication. I'm concerned about what the next six months really will be bringing our way.
 






This is true. Menveo is a dog with a finite limit as to how much it can grow due to the fact that it needs to be reconstituted. Unlike vaccines like pentacel, that reconstitution can't be justified with shot savings or schedule convenience. Also, we're running up against the sanofi contracts and those are pretty entrenched. We were able to draw out some of that business for awhile but sanofi is getting more aggressive about contract compliance and it's getting harder to convince docs they can buy some Menveo while on their sanofi agreement. And, don't even get me started on Menactra's 9 month indication. I'm concerned about what the next six months really will be bringing our way.

Thanks for stopping by, Sanofi.
 












This is true. Menveo is a dog with a finite limit as to how much it can grow due to the fact that it needs to be reconstituted. Unlike vaccines like pentacel, that reconstitution can't be justified with shot savings or schedule convenience. Also, we're running up against the sanofi contracts and those are pretty entrenched. We were able to draw out some of that business for awhile but sanofi is getting more aggressive about contract compliance and it's getting harder to convince docs they can buy some Menveo while on their sanofi agreement. And, don't even get me started on Menactra's 9 month indication. I'm concerned about what the next six months really will be bringing our way.

menveo is NOT a "dog". It has far higher #s than menactra will EVER have. we need to have better staff education or something because I have lost several newly won accounts because they had reconstitution problems. 2 of these were offices that have used pentacel and never had an issue.
 






menveo is NOT a "dog". It has far higher #s than menactra will EVER have. we need to have better staff education or something because I have lost several newly won accounts because they had reconstitution problems. 2 of these were offices that have used pentacel and never had an issue.

Staff Education?? Isn't that your job?

Did you inservice the account at the time of use or just book the order and move on?
 






menveo is NOT a "dog". It has far higher #s than menactra will EVER have. we need to have better staff education or something because I have lost several newly won accounts because they had reconstitution problems. 2 of these were offices that have used pentacel and never had an issue.

Just walked out of my second office today that told me Sanofi was going to price match us and they won't be going with Menveo. Has anyone else heard this?